Novavax, Inc. (NVAX)
12.43
-0.32
(-2.51%)
USD |
NASDAQ |
Oct 12, 12:06
Novavax Net Income (TTM) : -247.73M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -247.73M |
| March 31, 2026 | -87.84M |
| December 31, 2025 | 440.30M |
| September 30, 2025 | 341.74M |
| June 30, 2025 | 422.82M |
| March 31, 2025 | 478.70M |
| December 31, 2024 | -187.50M |
| September 30, 2024 | -284.86M |
| June 30, 2024 | -294.33M |
| March 31, 2024 | -398.71M |
| December 31, 2023 | -545.06M |
| September 30, 2023 | -548.92M |
| June 30, 2023 | -586.76M |
| March 31, 2023 | -1.155B |
| December 31, 2022 | -657.94M |
| September 30, 2022 | -1.322B |
| June 30, 2022 | -1.476B |
| March 31, 2022 | -1.318B |
| December 31, 2021 | -1.744B |
| September 30, 2021 | -1.075B |
| June 30, 2021 | -949.91M |
| March 31, 2021 | -615.11M |
| December 31, 2020 | -418.26M |
| September 30, 2020 | -272.52M |
| June 30, 2020 | -93.26M |
| Date | Value |
|---|---|
| March 31, 2020 | -115.34M |
| December 31, 2019 | -132.69M |
| September 30, 2019 | -150.20M |
| June 30, 2019 | -176.72M |
| March 31, 2019 | -181.61M |
| December 31, 2018 | -184.75M |
| September 30, 2018 | -186.26M |
| June 30, 2018 | -186.29M |
| March 31, 2018 | -186.27M |
| December 31, 2017 | -183.77M |
| September 30, 2017 | -190.04M |
| June 30, 2017 | -211.68M |
| March 31, 2017 | -246.57M |
| December 31, 2016 | -279.97M |
| September 30, 2016 | -301.66M |
| June 30, 2016 | -268.53M |
| March 31, 2016 | -209.82M |
| December 31, 2015 | -156.94M |
| September 30, 2015 | -109.68M |
| June 30, 2015 | -96.28M |
| March 31, 2015 | -93.51M |
| December 31, 2014 | -82.95M |
| September 30, 2014 | -65.46M |
| June 30, 2014 | -61.03M |
| March 31, 2014 | -55.80M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Moderna, Inc. | -3.151B |
| Merck & Co., Inc. | 3.169B |
| Pfizer Inc. | 4.373B |
| Agenus, Inc. | 91.94M |
| Editas Medicine, Inc. | -73.95M |